Global Inequality in Type 1 Diabetes: a Comparison of Switzerland and Low-and Middle-Income Countries

Pediatr Endocrinol Rev. 2020 Mar;17(Suppl 1):210-219. doi: 10.17458/per.vol17.2020.mps.type1diabetescomparison.

Abstract

Globally it is estimated that over 1 million children and adolescents have Type 1 diabetes with large variations in incidence between different contexts. Health systems need to provide a variety of elements to ensure appropriate diabetes care, such as service delivery; healthcare workforce; information; medical products and technologies; financing and leadership and governance. Describing these elements between Geneva, Switzerland, a high-income country with high spending on healthcare and a large density of doctors, and low- and middle-income countries this article aims to highlight the global inequality of diabetes care. Type 1 diabetes can serve as a litmus as we move towards the centenary of the discovery of insulin and beyond as there is a need for a global movement to ensure that innovation in the management of diabetes benefits the whole diabetes community and not just a select few.

Keywords: Access; Insulin; Type 1 diabetes.

Publication types

  • Comparative Study

MeSH terms

  • Delivery of Health Care
  • Developing Countries
  • Diabetes Mellitus, Type 1*
  • Global Health
  • Humans
  • Socioeconomic Factors
  • Switzerland